About Capillary Biomedical
Capillary Biomedical is a company based in Irvine (United States) founded in 2014 was acquired by Tandem Diabetes in July 2022. Capillary Biomedical has raised $3 million across 4 funding rounds from investors including Tandem Diabetes, HHS and Pasadena Angels. The company has 1,922 employees as of December 31, 2021. Capillary Biomedical operates in a competitive market with competitors including Dexcom, Livongo, Bigfoot Biomedical, Senseonics and One Drop, among others.
- Headquarter Irvine, United States
- Employees 1922 as on 31 Dec, 2021
-
Sectors
HealthcareTechnology
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$3 M (USD)
in 4 rounds
-
Latest Funding Round
$1.5 M (USD), Debt – Conventional
Oct 07, 2020
-
Investors
Tandem Diabetes
& 9 more
-
Employee Count
1922
as on Dec 31, 2021
-
Acquired by
Tandem Diabetes
(Jul 21, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Capillary Biomedical
Unlock access to complete
Unlock access to complete
Software Development Team
79 people
Sales and Marketing
32 people
Leadership Team
31 people
Finance and Accounting
14 people
Human Resources and Administration
14 people
Operations Team
13 people
Senior Team
13 people
Product Management Team
11 people
Unlock access to complete
Funding Insights of Capillary Biomedical
Capillary Biomedical has successfully raised a total of $3M across 4 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $1.5 million completed in October 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Capillary Biomedical
Capillary Biomedical has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Tandem Diabetes, HHS and Pasadena Angels.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A charitable trust focused on healthcare and research funding.
|
Locked | Locked | Locked | |
|
Seed-stage venture capital funding is provided by Cove Fund.
|
Locked | Locked | Locked | |
|
Angel investors are matched with high-growth SMEs across sectors.
|
Locked | Locked | Locked |
Investor details for Capillary Biomedical
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Capillary Biomedical
Investment portfolio details for Capillary Biomedical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Capillary Biomedical
Detailed financials for Capillary Biomedical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Capillary Biomedical Comparisons
Peer comparison for Capillary Biomedical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Capillary Biomedical
Capillary Biomedical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Dexcom, Livongo, Bigfoot Biomedical, Senseonics and One Drop, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Wearable glucose monitoring patches are provided for real-time data tracking.
|
|
| Locked | Locked | Locked |
Provider of smart devices for diabetes management for patients and doctors
|
|
| Locked | Locked | Locked |
Developer of a closed-loop automated insulin delivery system
|
|
| Locked | Locked | Locked |
Implantable continuous glucose monitoring systems are provided for diabetes management.
|
|
| Locked | Locked | Locked |
Provider of workforce healthcare solutions
|
|
| Locked | Locked | Locked |
Gamified apps for diabetes management and therapy are provided.
|
Detailed competitors of Capillary Biomedical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Capillary Biomedical
Complete news archive for Capillary Biomedical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Capillary Biomedical
Capillary Biomedical was founded in 2014.
Capillary Biomedical is headquartered in Irvine, United States. It is registered at Irvine, California, United States.
Capillary Biomedical is a funded company, having raised a total of $3M across 4 funding rounds to date.
As of Dec 31, 2021, the latest employee count at Capillary Biomedical is 1,922.
Capillary Biomedical was founded in 2014 and is based in Irvine, United States. The company operates in the biomedical sector, focusing on devices for diabetes management. A small implant is placed under the abdominal skin through an outpatient procedure, where glucose levels in interstitial fluid are measured optically using infrared spectrometry. Data is transmitted wirelessly to external receivers, mobile devices, or insulin pumps, allowing real-time monitoring of glucose trends.
Capillary Biomedical's top competitors include Dexcom, Senseonics and Bigfoot Biomedical.
Capillary Biomedical has 10 investors. Key investors include Tandem Diabetes, HHS, Pasadena Angels, Helmsley Charitable Trust, and Cove Fund.